A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma

Effects of Interleukin-9 Blockade on Chronic Airway Inflammation in Murine Asthma Models

(2013) Myung Shin Kim et al.   Allergy Asthma & Immunology Research

From interleukin-9 to T helper 9 cells

(2012) Michael Stassen et al.   Annals of the New York Academy of Sciences

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

(2012) Ian D Pavord et al.   LANCET

Lebrikizumab Treatment in Adults with Asthma

(2011) Jonathan Corren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma

(2011) Joseph M Parker et al.   BMC Pulmonary Medicine

IL-9 Governs Allergen-induced Mast Cell Numbers in the Lung and Chronic Remodeling of the Airways

(2010) Jennifer Kearley et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Efficacy and Safety of Subcutaneous Omalizumab vs Placebo as Add-on Therapy to Corticosteroids for Children and Adults With Asthma

(2010) Gustavo J. Rodrigo et al.   CHEST

Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers

(2009) Barbara White et al.   CLINICAL THERAPEUTICS

Randomized trial of the effect of drug presentation on asthma outcomes: The American Lung Association Asthma Clinical Research Centers

(2009) Robert A. Wise et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY